| pubmed-article:15235901 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15235901 | lifeskim:mentions | umls-concept:C0003232 | lld:lifeskim |
| pubmed-article:15235901 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:15235901 | lifeskim:mentions | umls-concept:C0079459 | lld:lifeskim |
| pubmed-article:15235901 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
| pubmed-article:15235901 | lifeskim:mentions | umls-concept:C0746883 | lld:lifeskim |
| pubmed-article:15235901 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:15235901 | lifeskim:mentions | umls-concept:C0023981 | lld:lifeskim |
| pubmed-article:15235901 | lifeskim:mentions | umls-concept:C0332167 | lld:lifeskim |
| pubmed-article:15235901 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:15235901 | pubmed:dateCreated | 2005-1-6 | lld:pubmed |
| pubmed-article:15235901 | pubmed:abstractText | Febrile neutropenia (FN) remains a major dose-limiting complication among patients treated with chemotherapy. Haematopoietic colony stimulating factors (G-CSF and GM-CSF) made possible a significant improvement in the management of FN, both in the therapeutic and in the prophylactic approach. The use of antibiotic prophylaxis also permits a definite reduction of severe infections during neutropenia. Nevertheless, the possible role of these two interventions for secondary prevention of FN is still unclear. | lld:pubmed |
| pubmed-article:15235901 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15235901 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15235901 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15235901 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15235901 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15235901 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15235901 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15235901 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15235901 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15235901 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15235901 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:15235901 | pubmed:issn | 0941-4355 | lld:pubmed |
| pubmed-article:15235901 | pubmed:author | pubmed-author:KlasterskyJJ | lld:pubmed |
| pubmed-article:15235901 | pubmed:author | pubmed-author:AlexopoulosC... | lld:pubmed |
| pubmed-article:15235901 | pubmed:author | pubmed-author:ReussKK | lld:pubmed |
| pubmed-article:15235901 | pubmed:author | pubmed-author:PaesmansMM | lld:pubmed |
| pubmed-article:15235901 | pubmed:author | pubmed-author:AounMM | lld:pubmed |
| pubmed-article:15235901 | pubmed:author | pubmed-author:CherifiSS | lld:pubmed |
| pubmed-article:15235901 | pubmed:author | pubmed-author:LalamiYY | lld:pubmed |
| pubmed-article:15235901 | pubmed:author | pubmed-author:Munoz-BermeoR... | lld:pubmed |
| pubmed-article:15235901 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15235901 | pubmed:volume | 12 | lld:pubmed |
| pubmed-article:15235901 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15235901 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15235901 | pubmed:pagination | 725-30 | lld:pubmed |
| pubmed-article:15235901 | pubmed:meshHeading | pubmed-meshheading:15235901... | lld:pubmed |
| pubmed-article:15235901 | pubmed:meshHeading | pubmed-meshheading:15235901... | lld:pubmed |
| pubmed-article:15235901 | pubmed:meshHeading | pubmed-meshheading:15235901... | lld:pubmed |
| pubmed-article:15235901 | pubmed:meshHeading | pubmed-meshheading:15235901... | lld:pubmed |
| pubmed-article:15235901 | pubmed:meshHeading | pubmed-meshheading:15235901... | lld:pubmed |
| pubmed-article:15235901 | pubmed:meshHeading | pubmed-meshheading:15235901... | lld:pubmed |
| pubmed-article:15235901 | pubmed:meshHeading | pubmed-meshheading:15235901... | lld:pubmed |
| pubmed-article:15235901 | pubmed:meshHeading | pubmed-meshheading:15235901... | lld:pubmed |
| pubmed-article:15235901 | pubmed:meshHeading | pubmed-meshheading:15235901... | lld:pubmed |
| pubmed-article:15235901 | pubmed:meshHeading | pubmed-meshheading:15235901... | lld:pubmed |
| pubmed-article:15235901 | pubmed:meshHeading | pubmed-meshheading:15235901... | lld:pubmed |
| pubmed-article:15235901 | pubmed:meshHeading | pubmed-meshheading:15235901... | lld:pubmed |
| pubmed-article:15235901 | pubmed:meshHeading | pubmed-meshheading:15235901... | lld:pubmed |
| pubmed-article:15235901 | pubmed:meshHeading | pubmed-meshheading:15235901... | lld:pubmed |
| pubmed-article:15235901 | pubmed:meshHeading | pubmed-meshheading:15235901... | lld:pubmed |
| pubmed-article:15235901 | pubmed:meshHeading | pubmed-meshheading:15235901... | lld:pubmed |
| pubmed-article:15235901 | pubmed:meshHeading | pubmed-meshheading:15235901... | lld:pubmed |
| pubmed-article:15235901 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15235901 | pubmed:articleTitle | A prospective randomised evaluation of G-CSF or G-CSF plus oral antibiotics in chemotherapy-treated patients at high risk of developing febrile neutropenia. | lld:pubmed |
| pubmed-article:15235901 | pubmed:affiliation | Department of Médecine Interne and Laboratoire d'Investigations Cliniques, H-J Tagnon, Institut Jules Bordet, Centre des Tumeurs de l'Université Libre de Bruxelles, Rue Héger Bordet 1, 1000 Brussels, Belgium. yassine.lalami@bordet.be | lld:pubmed |
| pubmed-article:15235901 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15235901 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15235901 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:15235901 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15235901 | lld:pubmed |
